Home / Recalls / SUN PHARMACEUTICAL INDUSTRIES INC / D-0044-2024

D-0044-2024 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

Recall Details

Product Type
Drugs
Report Date
October 25, 2023
Initiation Date
October 4, 2023
Termination Date
February 2, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
144 bottles

Product Description

Bupropion Hydrochloride Extended-Release Tablets USP (SR), 150 mg, 60 tablets bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-737-86

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide in the USA.

Code Information

Lot #: HAD0360A, Exp. 12/2023

Other recalls by SUN PHARMACEUTICAL INDUSTRIES INC

  • D-0476-2026 Class II — Fluocinonide, USP, 0.05% Cream, 30g tube, Rx only, Mfd by: Taro Pharmaceuticals (March 25, 2026)
  • D-0475-2026 Class II — Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals (March 25, 2026)
  • D-0477-2026 Class II — Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals (March 25, 2026)
  • D-0342-2026 Class II — Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceu (January 27, 2026)
  • D-0256-2026 Class III — Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx o (December 30, 2025)
  • D-0257-2026 Class III — Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator (November 26, 2025)
  • D-0145-2026 Class II — Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Man (October 28, 2025)
  • D-0146-2026 Class II — Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, Man (October 28, 2025)
  • D-0147-2026 Class II — Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, Man (October 28, 2025)
  • D-0150-2026 Class II — Lisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Man (October 28, 2025)